Fundraising FoxBiotech Startups
11,077 companies tagged Biotech, with their investors and founders.
0 investors
Memgen develops viral, cell-based, and vaccine adjuvant immunotherapies built on its proprietary CD40 ligand technology for treating cancer. Its lead candidate, MEM-288, combines the CD40 ligand with interferon beta and is in phase 1 clinical trials for advanced non-small cell lung cancer.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing therapeutics for metabolic diseases linked to age-related mitochondrial dysfunction, particularly insulin resistance and type 2 diabetes.
0 investors
0 investors
A clinical-stage biotech company developing novel drugs based on isotope-selective modulation technology, with patented drug compositions and a proprietary development platform currently in clinical trials.
0 investors
0 investors
0 investors
0 investors
0 investors
MetriTrack develops the FDA-cleared BVN model G-2000 (Breast Volume Navigator), an ultrasound system using dynamic mapping with anatomical referencing to locate and map breast lesions in women with dense breast tissue. The device targets supplemental breast cancer screening and care for a patient population underserved by mammography alone.
0 investors
0 investors
0 investors
Mevion Medical Systems builds compact proton therapy systems, including the MEVION S250 series, used by cancer treatment centers and NCI-designated cancer centers for radiation oncology. The systems are marketed on their small footprint and lower capital and operating costs compared with other proton therapy platforms.
0 investors